Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    FC-6 and colorectal cancer
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver
Condition: Metastatic Colorectal Cancer
Interventions: Biological: cetuximab;   Drug: 5-FU;   Drug: oxaliplatin;   Drug: leucovorin

Study has passed its completion date and status has not been verified in more than two years.